Safety and Effectiveness of Ramucirumab in Patients with Advanced Gastric Cancer

Status: open

Safety and Effectiveness of Ramucirumab in Patients with Advanced Gastric Cancer in European Union and North America: A prospective Observational Registry.

Treatment for Gastric (Stomach) Cancer

Contact Us Or call (251) 665-8000

Description

Inclusion Criteria: Advanced gastric cancer or GEJ adenocarcinoma that has progressed after prior chemotherapy and have initiated Ramucirumab treatment. Exclusion Criteria: Received more than 1 line of chemotherapy for advanced gastric or GEJ, or currently participating in any other study.

Sponsors

This trial is sponsored by Eli Lilly.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

    This link will open in a new tab or window.